CellChorus's mission is to apply artificial intelligence to visually evaluate how individual cells perform over time. The company offers its AI-powered TIMING™ platform and contract research services to biopharmaceutical companies and academic institutions to accelerate the development of cell-based therapies.
| Customer | Success Story | Source |
|---|---|---|
| Authors from MD Anderson Cancer Center, together with CellChorus, published data describing the design of a novel CAR27 NK therapy using the TIMING™ platform to quantify differences in serial killing. | ||
| Collaborated with CellChorus to validate the application of TIMING technology for analyzing patient responses to CAR T‑cell therapy. | ||
Nice Try Sign up to Ethos to access the full customer list Sign up to Ethos | Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. | Source |
Another Company | Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. | Source |
One More Company | Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sunt in culpa qui officia deserunt mollit anim id est laborum. | Source |
Nice Try | Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. | Source |
Another Company | Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. | Source |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos